首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India
【24h】

Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India

机译:VIA和HPV检测在印度宫颈癌筛查示范项目中作为主要筛查和顺序筛查测试的诊断准确性

获取原文
获取原文并翻译 | 示例
           

摘要

Visual inspection after acetic acid application (VIA) and human papillomavirus (HPV) detection tests have been recommended to screen women for cervical cancer in low and middle income countries. A demonstration project in rural India screened 39,740 women with both the tests to compare their accuracies in real population setting. The project also evaluated the model of screening women in the existing primary health care facilities, evaluating the screen positive women with colposcopy (and biopsy) in the same setup and recalling the women diagnosed to have disease for treatment at tertiary center. Accuracy of VIA and HPV test used sequentially was also studied. VIA was performed by trained health workers and Hybrid Capture II (HC II) assay was used for oncogenic HPV detection. Test positivity was 7.1% for VIA and 4.7% for HC II. Detection rate of CIN 3+ disease was significantly higher with HC II than VIA. Sensitivities of VIA and HC II to detect 162 histology proved CIN 3+ lesions were 67.9 and 91.2%, respectively after adjusting for verification bias. Specificity for the same disease outcome and verification bias correction was 93.2% for VIA and 96.9% for HC II. Triaging of VIA positive women with HPV test would have considerably improved the positive predictive value (4.0 to 37.5% to detect CIN 3+) without significant drop in sensitivity. All VIA positive women and 74.0% of HC II positive women had colposcopy. There was high compliance to treatment and significant stage-shift of the screen-detected cancers towards more early stage.
机译:在低收入和中等收入国家,建议使用乙酸(VIA)和人乳头瘤病毒(HPV)检测试验后进行目视检查,以筛查女性宫颈癌。印度农村地区的一个示范项目对39,740名妇女进行了两项测试,以比较她们在实际人口中的准确性。该项目还评估了在现有的初级卫生保健机构中对妇女进行筛查的模型,在相同的设置中通过阴道镜检查(和活检)对筛查阳性的妇女进行了评估,并召回了被诊断患有疾病的妇女在第三中心进行治疗。还研究了依次使用的VIA和HPV测试的准确性。 VIA由训练有素的卫生工作者进行,Hybrid Capture II(HC II)分析用于检测致癌性HPV。对于VIA和HC II,测试阳性率为7.1%。 HC II对CIN 3+疾病的检出率明显高于VIA。调整验证偏倚后,VIA和HC II对162种组织学的敏感性证明CIN 3+病变分别为67.9%和91.2%。相同疾病结局和验证偏倚校正的特异性对于VIA是93.2%,对于HC II是96.9%。通过HPV测试对VIA阳性女性进行分类将大大提高阳性预测值(检测CIN 3+为4.0至37.5%),而敏感性没有明显下降。所有VIA阳性妇女和HC II阳性妇女中74.0%接受阴道镜检查。对治疗的依从性很高,并且筛查到的癌症朝着更早期阶段的明显阶段转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号